McKinsey exec faces questions on opioid, FDA consulting work
The IndependentFor free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The top executive for global consulting firm McKinsey & Company faced congressional questions Wednesday about the company's work for U.S. health regulators even as it advised opioid drugmakers on how to boost sales of their prescription painkillers. The overlapping work included McKinsey staffers advising the FDA on overhauling its approach to drug safety, according to the committee's review of thousands of company documents. Sternfels told the committee that McKinsey's FDA contracts focused on “organizational support,” and did not pertain to opioids or drug “safety standards." At a separate Senate hearing Tuesday, the head of FDA's drug center director told lawmakers McKinsey's work was about “organizational design and did not entail involvement in product regulation."
History of this topic
McKinsey & Company to pay $650 million for role in opioid crisis
NPR
Consulting firm McKinsey to pay $650 million to resolve US criminal opioid probe
CNN
McKinsey & Company agrees to pay $650 million for helping Purdue Pharma boost opioid sales
India Today
McKinsey to pay $650m to settle US opioid consulting probe
Al Jazeera
Justice Department is investigating McKinsey consulting firm’s role in opioid epidemic
CNN
Consulting giant McKinsey agrees to $78 million settlement in opioid case
Hindustan TimesConsulting firm McKinsey agrees to $78 million settlement with insurers over opioids
Associated Press
McKinsey reaches deal with US local governments over opioids
Al Jazeera
FDA chief’s long-promised opioid review faces skepticism
Associated Press
4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis
NPR
Pharmacies face 1st trial over role in opioid crisis
LA Times
Senators question FDA on work with opioid maker consultant
Associated Press
McKinsey agrees to pay nearly $600M over opioid crisis
Associated Press
McKinsey agrees to pay nearly $600M over opioid crisis
The Independent
McKinsey to pay $573m over claims it fuelled US opioid crisis
Al JazeeraDiscover Related
)
